Gabriela Tuttrup
Neurology with Special Qualifications in Child Neurology · Temple, TXNPI 1376962324
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 191 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by UCB, Inc. at 27.8% of the total.
Across 191 payments — averaging $38.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$2K
- DIXI Medical USA Corp$981
- Jazz Pharmaceuticals Inc.$964
- SK Life Science, Inc.$898
- Livanova USA, Inc.$317
- Neurelis, Inc.$289
- plus $2K from 20 others
Across 1 payment — averaging $12,012 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB Biosciences Inc.$12K
What the payments were for
- Food & beverage$7,343100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 47 | $2,039 |
| DIXI Medical USA Corp | 2 | $981 |
| Jazz Pharmaceuticals Inc. | 39 | $964 |
| SK Life Science, Inc. | 16 | $898 |
| Livanova USA, Inc. | 8 | $317 |
| Neurelis, Inc. | 8 | $289 |
| PTC Therapeutics, Inc. | 11 | $232 |
| Biogen | 10 | $230 |
| Sarepta Therapeutics, Inc. | 11 | $198 |
| Eisai Inc. | 4 | $182 |
| Sanofi | 3 | $158 |
| Biocodex, Inc. | 3 | $143 |
| Catalyst Pharmaceuticals, Inc. | 4 | $122 |
| Upsher-smith Laboratories LLC | 3 | $91 |
| Genentech USA, Inc. | 4 | $80 |
| Immedica Pharma US, Inc. | 3 | $71 |
| Aucta Pharmaceuticals, Inc. | 3 | $71 |
| Azurity Pharmaceuticals, Inc. | 2 | $47 |
| Argenx US, Inc. | 1 | $44 |
| Novartis | 1 | $42 |
| Biomarin Pharmaceutical Inc. | 3 | $40 |
| Mallinckrodt Enterprises LLC | 1 | $28 |
| Acadia Pharmaceuticals Inc | 1 | $24 |
| Mirum Pharmaceuticals, Inc. | 1 | $19 |
| NS Pharma, Inc. | 1 | $17 |
| Avanir Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,343 in reported general payments places this provider in the 80th percentile of 193 neurology with special qualifications in child neurology providers in Texas.
See all neurology with special qualifications in child neurology providers in Texas →
Other neurology with special qualifications in child neurology in Temple
- Roy EltermanDallas$5.9M
- Huda ZoghbiHouston$5.5M
- Diana CastroDenton$343K
- Shade MoodyHouston$194K
- Mary Kay KoenigHouston$171K
- Michael PerryFort Worth$162K
- Raphael SchiffmannDallas$88K
- Mauricio Delgado-AyalaDallas$75K
- Kaitlin BatleyDallas$74K
- Warren MarksFort Worth$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.